Liquid biopsy in triple-negative breast cancer: Unlocking the potential of precision oncology

Authors

R Mazzeo, University of Udine
J Sears, Washington University School of Medicine in St. Louis
L Palmero, University of Udine
S Bolzonello, National Cancer Institute
A A Davis, Washington University School of Medicine in St. Louis
L Gerratana, University of Udine
F Puglisi, University of Udine

Journal

ESMO Open

Publication Date

10-1-2024

Volume

9

Issue

10

First Page

103700

Document Type

Open Access Publication

DOI

10.1016/j.esmoop.2024.103700

Rights and Permissions

Mazzeo R, Sears J, Palmero L, Bolzonello S, Davis AA, Gerratana L, Puglisi F. Liquid biopsy in triple-negative breast cancer: unlocking the potential of precision oncology. ESMO Open. 2024 Oct;9(10):103700. doi: 10.1016/j.esmoop.2024.103700. © 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Mazzeo, R; Sears, J; Palmero, L; Bolzonello, S; Davis, A A; Gerratana, L; and Puglisi, F, "Liquid biopsy in triple-negative breast cancer: Unlocking the potential of precision oncology." ESMO Open. 9, 10. 103700 (2024).
https://digitalcommons.wustl.edu/oa_4/5269

Department

ICTS (Institute of Clinical and Translational Sciences)